Ticker Symbol: CMPI
Checkmate Pharmaceuticals Inc
$3.74 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001651431
Company Profile
Checkmate Pharmaceuticals, Inc. operates as a biotechnology company. The Company discovers and develops novel approaches for cancer immunotherapy such as immuno-oncology. Checkmate Pharmaceuticals serves patients worldwide.
Sector: N/A
Industry: N/A
Standard Industrial Classification Code (SIC code): N/A
Address: N/A
Website: checkmatepharma.com
CEO: N/A
Tags:
- Health Technology
- Biotechnology
- Commercial Services
- Miscellaneous Commercial Services
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
$0.02
(
0.19%)
Days Range: $10.50 - $10.50
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.19%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 22038218
Valuation
Market Cap: 23.1B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A